Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults

被引:134
|
作者
Lu, Jieli [1 ]
He, Jiang [2 ]
Li, Mian [1 ]
Tang, Xulei [3 ]
Hu, Ruying [4 ]
Shi, Lixin [5 ]
Su, Qing [6 ]
Peng, Kui [1 ]
Xu, Min [1 ]
Xu, Yu [1 ]
Chen, Yuhong [1 ]
Yu, Xuefeng [7 ]
Yan, Li [8 ]
Wang, Tiange [1 ]
Zhao, Zhiyun [1 ]
Qin, Guijun [9 ]
Wan, Qin [10 ]
Chen, Gang [11 ]
Dai, Meng [1 ]
Zhang, Di [1 ]
Gao, Zhengnan [12 ]
Wang, Guixia [13 ]
Shen, Feixia [14 ]
Luo, Zuojie [15 ]
Qin, Yingfen [15 ]
Chen, Li [16 ]
Huo, Yanan [17 ]
Li, Qiang [18 ]
Ye, Zhen [4 ]
Zhang, Yinfei [19 ]
Du, Rui [1 ]
Cheng, Di [1 ]
Liu, Chao [20 ]
Wang, Youmin [21 ]
Wu, Shengli [22 ]
Yang, Tao [23 ]
Deng, Huacong [24 ]
Li, Donghui [25 ]
Lai, Shenghan [26 ]
Bloomgarden, Zachary T. [27 ]
Chen, Lulu [28 ]
Zhao, Jiajun [29 ]
Mu, Yiming [30 ]
Ning, Guang [1 ]
Wang, Weiqing [1 ]
Bi, Yufang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Sch Med, Key Lab Endocrine Tumors,Minist Shanghai,Ruijin H, Shanghai, Peoples R China
[2] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA
[3] Lanzhou Univ, Hosp 1, Lanzhou, Gansu, Peoples R China
[4] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China
[5] Guiyang Med Coll, Affiliated Hosp, Guiyang, Guizhou, Peoples R China
[6] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai, Peoples R China
[7] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China
[8] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China
[9] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[10] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
[11] Fujian Med Univ, Fujian Prov Hosp, Fuzhou, Fujian, Peoples R China
[12] Dalian Municipal Cent Hosp, Dalian, Peoples R China
[13] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
[14] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[15] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China
[16] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China
[17] Nanchang Univ, Jiangxi Prov Peoples Hosp, Nanchang, Jiangxi, Peoples R China
[18] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China
[19] Cent Hosp Shanghai Jiading Dist, Shanghai, Peoples R China
[20] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China
[21] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China
[22] Karamay Municipal Peoples Hosp, Karamay, Xinjiang, Peoples R China
[23] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[24] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[25] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[26] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[27] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[28] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China
[29] Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
[30] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
CARDIOVASCULAR-DISEASE; NONDIABETIC HYPERGLYCEMIA; GLYCATED HEMOGLOBIN; REGRESSION-MODELS; MORTALITY; COHORT; A1C; PREVALENCE; GLYCEMIA; MEN;
D O I
10.2337/dc18-1390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Uncertainty remains regarding the predictive value of various glycemic measures as they relate to the risk of diabetes and its complications. Using the cutoffs recommended by the American Diabetes Association's 2010 criteria, we determined the associations of fasting plasma glucose (FPG), 2-h postload glucose (2h-PG), and HbA(1c) with the outcomes. RESEARCH DESIGN AND METHODS Baseline medical history, FPG, 2h-PG, and HbA(1c) were obtained from a population-based cohort of 193,846 adults aged >= 40 years in China during 2011-2012. A follow-up visit was conducted during 2014-2016 in order to assess incident diabetes, cardiovascular disease (CVD), cancer, and mortality. RESULTS We documented 8,063 cases of diabetes, 3,014 CVD-related events, 1,624 cases of cancer, and 2,409 deaths during up to 5 years of follow-up. Multivariable-adjusted risk ratios (95% CIs) of diabetes associated with prediabetes based on FPG of 100-125 mg/dL, 2h-PG of 140-199 mg/dL, or HbA(1c) of 5.7-6.4% (39-47 mmol/mol) were 1.60 (1.43-1.79), 2.72 (2.43-3.04), and 1.49 (1.36-1.62), respectively. Restricted cubic spline analyses suggested J-shaped associations of FPG, 2h-PG, and HbA(1c) levels with CVD, cancer, and mortality. Multivariable-adjusted hazard ratios (95% CIs) associated with untreated diabetes based on FPG >= 126 mg/dL, 2h-PG >= 200 mg/dL, or HbA(1c) >= 6.5% (48 mmol/mol) were 1.18 (1.05-1.33), 1.31 (1.18-1.45), and 1.20 (1.07-1.34) for CVD; 1.10 (0.92-1.32), 1.44 (1.25-1.67), and 1.08 (0.92-1.28) for cancer; and 1.37 (1.20-1.57), 1.57 (1.41-1.76), and 1.33 (1.17-1.52) for mortality, respectively. 2h-PG remained significantly associated with outcomes in models including FPG and HbA(1c) as spline terms. Furthermore, 2h-PG significantly improved the ability of the C statistic to predict diabetes, CVD, and mortality. CONCLUSIONS 2h-PG remains independently predictive of outcomes in models including FPG and HbA(1c). Therefore, in addition to FPG and HbA(1c), routine testing of 2h-PG should be considered in order to better assess the risks of outcomes.
引用
收藏
页码:1539 / 1548
页数:10
相关论文
共 50 条
  • [41] Predictive Value of Admission Plasma Glucose and Hemoglobin A1c on Inpatient Glycemic Control Assessed by Continuous Glucose Monitoring (CGM) in Medicine and Surgery Persons with Diabetes
    Castro-Revoredo, Iris A.
    Zhou, Siyu
    Urrutia, Maria A.
    Vellanki, Priyathama
    Idrees, Thaer
    Zabala, Zohyra
    Galindo, Rodolfo J.
    Peng, Limin
    Umpierrez, Guillermo
    DIABETES, 2024, 73
  • [42] Prevalence of prediabetes in healthy adults using hemoglobin A1c versus fasting plasma glucose - The GAPP study
    Blum, J.
    Aeschbacher, S.
    Schoen, T.
    Pumpol, K.
    Risch, M.
    Risch, L.
    Conen, D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 793 - 793
  • [43] Screening for glucose intolerance in polycystic ovary syndrome: hemoglobin A1C, fasting blood glucose or oral glucose tolerance test?
    Kelley, Carly E.
    Brown, Ann J.
    Setji, Tracy L.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (06) : 671 - 683
  • [44] The Use of Fasting Plasma Glucose and Glycosylated Hemoglobin A1c for Diabetes Mellitus after Renal Transplantation.
    Valderhaug, Tone G.
    Jenssen, Trond G.
    Hartmann, Anders
    Midtvedt, Karsten
    Holdaas, Hallvar
    Reiersther, Anna V.
    Hjelmesth, Joran
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 595 - 595
  • [45] Diabetes Screening With Hemoglobin A1c Versus Fasting Plasma Glucose in a Multiethnic Middle-School Cohort
    Buse, John B.
    Kaufman, Francine R.
    Linder, Barbara
    Hirst, Kathryn
    El Ghormli, Laure
    Willi, Steven
    DIABETES CARE, 2013, 36 (02) : 429 - 435
  • [46] Increased Arterial Stiffness in Prediabetic Subjects Recognized by Hemoglobin A1c with Postprandial Glucose but Not Fasting Glucose Levels
    Li, Chung-Hao
    Lu, Feng-Hwa
    Yang, Yi-Ching
    Wu, Jin-Shang
    Chang, Chih-Jen
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [47] 1-Hour Postload Glucose: Early Screening for High Risk of Type 2 Diabetes in Koreans With Normal Fasting Glucose
    Lee, Min Jin
    Bae, Ji Hyun
    Khang, Ah Reum
    Yi, Dongwon
    Kim, Joo Yeon
    Kim, Su Hyun
    Kim, Dong Hee
    Kang, Dasol
    Park, Sujin
    Jeon, Yun Kyung
    Kim, Sang Soo
    Kim, Bo Hyun
    Yun, Mi Sook
    Kang, Yang Ho
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [48] Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose
    Abdul-Ghani, Muhammad A.
    Williams, Ken
    DeFronzo, Ralph
    Stern, Michael
    DIABETES CARE, 2006, 29 (07) : 1613 - 1618
  • [49] The Reporting of Estimated Glucose with Hemoglobin A1c
    Sacks, David B.
    Bergenstal, Richard M.
    McLaughlin, Susan
    CLINICAL CHEMISTRY, 2010, 56 (04) : 545 - 546
  • [50] Concordance of A1C, Fasting Glucose, and Oral Glucose Tolerance Test Criteria for Defining Remission of Diabetes
    Retnakaran, Ravi
    Pu, Jiajie
    Emery, Alexandra
    Kramer, Caroline K.
    Zinman, Bernard
    DIABETES CARE, 2023, 46 (03) : E83 - E84